| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.18 | 0.0009 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.15 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.003 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.003 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.088 | 0.004 |